Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.380 | 39.630 | 38.250 |
Bonds | 98.000 | 98.200 | 0.200 |
Convertible | 0.620 | 0.620 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.731 | 10.556 |
Price to Book | 2.765 | 1.368 |
Price to Sales | 0.325 | 0.747 |
Price to Cash Flow | 4.187 | 7.433 |
Dividend Yield | 1.902 | 5.285 |
5 Years Earnings Growth | - | 12.449 |
Name | Net % | Category Average |
---|---|---|
Corporate | 87.133 | 76.962 |
Cash | 1.378 | 11.803 |
Government | 9.328 | 12.995 |
Securitized | 1.830 | 4.158 |
Number of long holdings: 375
Number of short holdings: 14
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
United States Treasury Bonds 2% | - | 5.15 | - | - | |
UnitedHealth Group Inc. 5% | - | 1.40 | - | - | |
Swisscom Finance B.V. 3.5% | XS2827696035 | 1.14 | - | - | |
Roche Holdings, Inc. 5.338% | - | 1.00 | - | - | |
NBN Co Ltd. 4.125% | XS2590621103 | 1.00 | - | - | |
Grand City Properties SA 0.125% | XS2282101539 | 0.89 | - | - | |
Mars Inc. 4.65% | - | 0.88 | - | - | |
JPMorgan Chase & Co. 2.58% | - | 0.81 | - | - | |
AstraZeneca Finance LLC 4.875% | - | 0.77 | - | - | |
Amgen Inc. 5.25% | - | 0.76 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1849560120 | 165.96M | 1.97 | -0.18 | 0.84 | ||
Global Emerging Market DEH EUR | 55.86M | 0.99 | -3.04 | -0.18 | ||
LU0957781866 | 55.86M | 3.28 | -1.58 | - | ||
LU0757426498 | 37.43M | 1.82 | -1.42 | 2.48 | ||
TL Emerging Market Corporate Bonds | 37.43M | 0.32 | -2.97 | 1.80 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review